You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大行評級|里昂:重申石藥集團“跑贏大市”評級 今年盈利有望反彈
格隆匯 02-27 13:40
里昂發佈研究報吿指,石藥集團發盈警,料2024財年純利按年跌26%至43億元,主要是由於帶量採購(VBP)對主要產品美素(Duomeisu)和津優力(Jinyouli)的影響。然而,考慮到最近完成的項目和未來更多潛在對外授權項目所帶來的可觀合作收入,該行認為公司今年盈利狀況或達到拐點。該行認為,短期市場情緒受壓,但當前股價呈吸引力的風險回報。該行表示,將集團去年、今年及明年盈利預測分別降22.8%、升27.8%及降4.4%,同時維持其目標價為12港元,認為最壞時刻已過,今年盈利有望反彈,重申其評級為“跑贏大市”。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account